Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
A ALIMENTARY TRACT AND METABOLISM
A07 ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS
A07D ANTIPROPULSIVES
A07DA Antipropulsives
A07DA06 Eluxadoline
D10403 Eluxadoline (USAN/INN) <US>
USP drug classification [BR:br08302]
Gastrointestinal Agents
Anti-diarrheal Agents
Eluxadoline
D10403 Eluxadoline (USAN/INN)
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01564 Opioid receptor agonist
D10403 Eluxadoline
Analgesic
DG01586 Opioid receptor antagonist
D10403 Eluxadoline
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Opioid
OPRM1
D10403 Eluxadoline (USAN/INN) <US>
OPRK1
D10403 Eluxadoline (USAN/INN) <US>
OPRD1
D10403 Eluxadoline (USAN/INN) <US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D10403
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D10403
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D10403